Out of 5 analysts covering Diploma PLC (LON:DPLM), 3 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 60% are positive. Diploma PLC has been the topic of 21 analyst reports since November 12, 2015 according to StockzIntelligence Inc. Below is a list of Diploma PLC (LON:DPLM) latest ratings and price target changes.
01/09/2016 Broker: Barclays Capital Rating: Equal Weight Old Target: GBX 836.00 New Target: GBX 836.00 Maintain
31/08/2016 Broker: Numis Securities Rating: Hold Old Target: GBX 760.00 New Target: GBX 800.00 Maintain
31/08/2016 Broker: Peel Hunt Rating: Add Old Target: GBX 690.00 New Target: GBX 900.00 Upgrade
19/08/2016 Broker: Jefferies Rating: Buy Old Target: GBX 885.00 New Target: GBX 970.00 Maintain
17/08/2016 Broker: Barclays Capital Rating: Equal Weight Old Target: GBX 831.00 New Target: GBX 836.00 Downgrade
17/05/2016 Broker: RBC Capital Markets Rating: Outperform Old Target: GBX 950.00 New Target: GBX 950.00 Maintain
16/05/2016 Broker: Numis Securities Rating: Hold Old Target: GBX 760.00 New Target: GBX 760.00 Maintain
16/05/2016 Broker: Peel Hunt Rating: Hold Old Target: GBX 690.00 New Target: GBX 690.00 Maintain
15/04/2016 Broker: Barclays Capital Rating: Overweight Old Target: GBX 811.00 New Target: GBX 831.00 Maintain
24/03/2016 Broker: Peel Hunt Rating: Hold Old Target: GBX 690.00 New Target: GBX 690.00 Maintain
The stock increased 0.68% or GBX 5.88 on September 13, hitting GBX 871.88. About 82,822 shares traded hands. Diploma PLC (LON:DPLM) has risen 37.46% since February 11, 2016 and is uptrending. It has outperformed by 20.97% the S&P500.
Diploma PLC is an international group of businesses supplying specialized technical services and products. The company has a market cap of 987.31 million GBP. The Firm is organized into three business sectors: Life Sciences, Seals and Controls. It has a 27 P/E ratio. The Life Sciences Sector businesses supply a range of consumables, instrumentation and related services to the healthcare and environmental industries.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.